Cardiac Rhythm Issue 42 – October 2018 EU edition

144

Highlights:

  • Novel anticoagulants associated with lower all-cause mortality compared to VKAs
  • CABANA trial provides important new data on clinical and quality of life effects of ablation for atrial fibrillation
  • Profile: Tim Betts
  • New guidelines on CV management during pregnancy

LEAVE A REPLY

Please enter your comment!
Please enter your name here